Hadef Soumia

Hadef Soumia

Université Larbi Ben Mhidi de Oum El Bouaghi - Oum El Bouaghi / Algeria
Natural Sciences / Biological Science
AD Scientific Index ID: 98486
جامعة العربي بن مهيدي أم البواقي
person_outline Hadef Soumia's MOST POPULAR ARTICLES
1-) Results of a randomized phase 2 study of PD 0332991, a cyclin-dependent kinase (CDK) 4/6 inhibitor, in combination with letrozole vs letrozole alone for first-line treatment of …RS Finn, JP Crown, K Boer, I Lang, RJ Parikh, A Breazna, SN Ho, ST Kim, ...Annals of Oncology 23, 43-43, 20121652012
2-) Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)T Bachelot, E Ciruelos, A Schneeweiss, F Puglisi, T Peretz-Yablonski, ...Annals of Oncology 30 (5), 766-773, 20191062019
3-) Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a …D Miles, E Ciruelos, A Schneeweiss, F Puglisi, T Peretz-Yablonski, ...Annals of Oncology 32 (10), 1245-1255, 2021622021
4-) Étude ethnobotanique de la plante médicinale Arbutus unedo L. dans la région de Sidi Bel Abbés en Algérie occidentaleA Bouzid, R Chadli, K BouzidPhytothérapie 15 (6), 373, 2017592017
5-) Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study …J Gligorov, B Ataseven, M Verrill, M De Laurentiis, KH Jung, HA Azim, ...European Journal of Cancer 82, 237-246, 2017562017